Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1996
10/08/1996US5563039 Tumor necrosis factor
10/08/1996US5563038 Detergent has lipophilic, hydrophilic segments
10/08/1996US5563032 Mosaic polypeptide and methods for detecting the hepatitis E virus
10/08/1996US5562905 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
10/08/1996CA2078141C Acyl phosphate esters and modification of proteins therewith
10/08/1996CA1338632C Cloning and sequencing of the gene which codes for a new pilinic subunit of bordetella pertussis
10/07/1996CA2170073A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
10/03/1996WO1996030766A1 Inhibition of tau-tau-association
10/03/1996WO1996030765A1 Assaying protein fragments in body fluids
10/03/1996WO1996030547A1 Method for diagnosis of epstein-barr virus associated disease
10/03/1996WO1996030539A1 Engineered acarid allergen and process for producing the same
10/03/1996WO1996030536A1 Egf-targeted nucleic acid delivery
10/03/1996WO1996030534A1 Adenovirus vectors for gene therapy
10/03/1996WO1996030532A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
10/03/1996WO1996030531A1 Gene expression in mammalian cells
10/03/1996WO1996030527A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors
10/03/1996WO1996030526A2 Bacillus thuringiensis alkaline protease and neutral protease genes
10/03/1996WO1996030525A1 BARLEY β-AMYLASE STRUCTURAL GENE
10/03/1996WO1996030523A2 Antigen presentation system based on retrovirus-like particles
10/03/1996WO1996030522A1 Dna molecule relating to suppression of gene expression and novel protein
10/03/1996WO1996030521A2 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid
10/03/1996WO1996030520A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
10/03/1996WO1996030519A1 Haemophilus adhesion proteins
10/03/1996WO1996030518A1 Plant pathogen resistance genes and uses thereof
10/03/1996WO1996030517A1 Genetic sequences conferring nematode resistance in plants and uses therefor
10/03/1996WO1996030516A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996WO1996030515A1 Methods and associated reagents for detecting modulators of cytokine action
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030513A1 Apoptosis regulating gene
10/03/1996WO1996030512A1 Conditional expression system
10/03/1996WO1996030511A1 Polymorphic and multicopy members of mhc gene families
10/03/1996WO1996030506A1 Antibody to human betacellulin and use thereof
10/03/1996WO1996030505A1 Methods for screening compounds for estrogenic activity
10/03/1996WO1996030504A1 Modified viral envelope polypeptide
10/03/1996WO1996030494A1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies
10/03/1996WO1996030459A1 Novel ice-controlling molecules and their applications
10/03/1996WO1996030407A1 Bifunctional thrombin inhibitors bearing highly truncated fibrinogen recognition exosite binding component
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030405A1 Peptides with growth promotion properties
10/03/1996WO1996030404A1 Intracellular signaling proteins and methods of use
10/03/1996WO1996030403A1 Methods of treating disorders of the eye
10/03/1996WO1996030402A1 Nucleotide and protein sequences of lats genes and methods based thereon
10/03/1996WO1996030400A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES
10/03/1996WO1996030398A1 Novel auto antigen
10/03/1996WO1996030389A1 Compositions for the diagnosis, prevention, and treatment of tumor progression
10/03/1996WO1996030387A1 Novel human cytomegalovirus dna sequences
10/03/1996WO1996030385A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996WO1996030353A1 Reversible protease inhibitors
10/03/1996WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/03/1996WO1996030326A1 Differentiating agents for the treatment of inflammatory intestinal diseases
10/03/1996WO1996030055A2 Radiolabeled peptides for diagnosis and therapy
10/03/1996WO1996030053A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/03/1996WO1996030052A1 Limbic system-associated membrane protein and dna
10/03/1996WO1996030043A1 Treatment for verotoxin-producing escherichia coli
10/03/1996WO1996030042A2 Methods of treating inflammation and compositions therefor
10/03/1996WO1996030041A1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution
10/03/1996WO1996030040A1 Monomeric insulin analog formulations
10/03/1996WO1996030038A1 Peptide growth factor having epidermal inducing activity
10/03/1996WO1996030037A1 Method of treating conditions associated with burn injuries
10/03/1996WO1996030031A1 Isolated stromal cells and methods of using the same
10/03/1996WO1996030006A1 Nitrosylated blood substitutes
10/03/1996WO1996029989A1 Stable protein:phospholipid compositions and methods____________
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1996029858A1 Transgenic plants with altered senescence characteristics
10/03/1996WO1996023884A3 Human peroxisome proliferator activated receptors
10/03/1996WO1996022373A3 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
10/03/1996WO1996003436A3 EQUINE η-INTERFERON
10/03/1996CA2218601A1 Treatment for verotoxin-producing escherichia coli
10/03/1996CA2217069A1 Novel ice-controlling molecules and their applications
10/03/1996CA2217009A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996CA2216878A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996CA2216842A1 Limbic system-associated membrane protein and dna
10/03/1996CA2216835A1 Human g-protein coupled receptors
10/03/1996CA2216799A1 Genetic sequences conferring nematode resistance in plants and uses therefor
10/03/1996CA2216755A1 Peptides with growth promotion properties
10/03/1996CA2216702A1 Nucleotide and protein sequences of lats genes and methods based thereon
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2216612A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors
10/03/1996CA2216516A1 Monomeric insulin analog formulations
10/03/1996CA2216445A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
10/03/1996CA2216428A1 Dna molecule relating to suppression of gene expression and novel protein
10/03/1996CA2216292A1 Haemophilus adhesion proteins
10/03/1996CA2216174A1 Gene expression in mammalian cells
10/03/1996CA2216151A1 Reversible protease inhibitors
10/03/1996CA2215836A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/03/1996CA2215496A1 Plant pathogen resistance genes and uses thereof
10/03/1996CA2215355A1 Antibody, hybridoma and use thereof
10/03/1996CA2215330A1 Methods of treating disorders of the eye
10/03/1996CA2215143A1 Isolated stromal cells and methods of using the same
10/03/1996CA2214988A1 Method of treating inflammation and compositions therefor
10/03/1996CA2214451A1 Conditional expression system
10/03/1996CA2191774A1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies
10/03/1996CA2191214A1 Apoptosis regulating gene
10/03/1996CA2191189A1 Methods and associated reagents for detecting modulators of cytokine action
10/02/1996EP0735140A2 Method for secretory production of protein
10/02/1996EP0735139A1 Heteropolymeric protein production
10/02/1996EP0735138A2 Fungal cell wall protein Cly4
10/02/1996EP0735048A1 Monomeric insulin analog formulations
10/02/1996EP0734530A1 Combinatorial libraries and methods for their use
10/02/1996EP0734529A1 Methods and materials for the detection of staphylococcus aureus
1 ... 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 ... 2916